Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1996-09-04
1998-03-10
Clardy, S. Mark
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514324, 514422, 548525, 546202, A61K 3156, A61K 3144, A61K 31445, C07D33352
Patent
active
057261687
ABSTRACT:
The invention provides novel benzothiophenes of the formula (I): ##STR1## wherein R.sub.1 is N-pyrrolidinyl or N-piperidinyl;
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4418068 (1983-11-01), Jones
patent: 5210211 (1993-05-01), Hodges et al.
Haudenschild, Christian C., "Pathobiology of Restenosis After Angioplasty", American Journal of Medicine, 94, 40-44 (1993).
Wilensky, Robert L. et al., "Methods and Devices for Local Drug Delivery in Coronary and Peripheral Arteries", Trends Cardiovasc Med, 3, 163-170 (1993).
Waller, Bruce F. et al., "Morphologic Observations Late After Coronary Balloon Angioplasty: Mechanisms of Acute Injury and Relationship to Restenosis.sup.1 ", Radiology, 174, 961-967 (1990).
Cullinan George Joseph
Kauffman Raymond Francis
Boone David E.
Cebulak Mary C.
Clardy S. Mark
Eli Lilly and Company
Sales James J.
LandOfFree
Lipophilic benzothiophenes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipophilic benzothiophenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipophilic benzothiophenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139541